[1]
|
Liu, N.N., Hang, T., Gao, X., et al. (2020) The Association between Soluble Suppression of Tumorigenicity-2 and Long-Term Prognosis in Patients with Coronary Artery Disease: A Meta-Analysis. PLoS ONE, 15, e0238775.
https://doi.org/10.1371/journal.pone.0238775
|
[2]
|
Qi, Z.W., Wu, D., Li, M., et al. (2020) The Pluripotent Role of Exosomes in Mediating Non-Coding RNA in Ventricular Remodeling after Myocardial Infarction. Life Sciences, 254, Article ID: 117761.
https://doi.org/10.1016/j.lfs.2020.117761
|
[3]
|
Song, Y.B., Li, J.B., Bian, S.Z., et al. (2018) Association between Low Free Triiodothyronine Levels and Poor Prognosis in Patients with Acute ST-Elevation Myocardial Infarction. BioMed Research International, 2018, Article ID: 9803851. https://doi.org/10.1155/2018/9803851
|
[4]
|
Henderson, K.K., Danzi, S., Paul, J.T., et al. (2009) Physiological Replacement of T3 Improves Left Ventricular Function in an Animal Model of Myocardial Infarction-Induced Congestive Heart Failure. Circulation: Heart Failure, 2, 243-252. https://doi.org/10.1161/CIRCHEARTFAILURE.108.810747
|
[5]
|
Hieda, M. and Goto, Y. (2020) Cardiac, Mechanoenergetics in Patients with Acute Myocardial Infarction: From Pressure-Volume Loop Diagram Related to Cardiac Oxygen Consumption. Heart Failure Clinics 16, 255-269.
https://doi.org/10.1016/j.hfc.2020.02.002
|
[6]
|
Jankauskiene, E., Orda, P., Barauskiene, G., et al. (2016) Relationship between Left Ventricular Mechanics and Low Free Triiodothyronine Levels after Myocardial Infarction: A Prospective Study. Internal and Emergency Medicine, 11, 391-398. https://doi.org/10.1007/s11739-015-1370-x
|
[7]
|
de Castro Alexandre, L., Fernandes, R.O., Ortiz, V.D., et al. (2016) Thyroid Hormones Improve Cardiac Function and Decrease Expression of Pro-Apoptotic Proteins in the Heart of Rats 14 Days after Infarction. Apoptosis, 21, 184-194.
https://doi.org/10.1007/s10495-015-1204-3
|
[8]
|
Razvi, S. (2019) Novel Uses of Thyroid Hormones in Cardiovascular Conditions. Endocrine, 66, 115-123.
https://doi.org/10.1007/s12020-019-02050-4
|
[9]
|
Antonio, Mancini, Chantal, et al. (2016) Thyroid Hormones, Oxidative Stress, and Inflammation. Mediators of inflammation, 2016, Article ID: 6757154. https://doi.org/10.1155/2016/6757154
|
[10]
|
Pantos, C., Mourouzis, I. and Cokkinos, D.V. (2011) New Insights into the Role of Thyroid Hormone in Cardiac Remodeling: Time to Reconsider? Heart Failure Reviews, 16, 79-96. https://doi.org/10.1007/s10741-010-9185-3
|
[11]
|
Pingitore, A., Mastorci, F., Piaggi, P., et al. (2019) Usefulness of Triiodothyronine Replacement Therapy in Patients with ST Elevation Myocardial Infarction and Borderline/Reduced Triiodothyronine Levels (from the THIRST Study). The American Journal of Cardiology, 123, 905-912. https://doi.org/10.1016/j.amjcard.2018.12.020
|
[12]
|
Brozaitiene, J., Skiriute, D., Burkauskas, J., et al. (2017) Deiodinases, Organic Anion Transporter Polypeptide Polymorphisms, and Thyroid Hormones in Patients with Myocardial Infarction. Genetic Testing and Molecular Biomarkers, 22, 270-278. https://doi.org/10.1089/gtmb.2017.0283
|
[13]
|
Ioanna, I., Iordanis, M., George, L., et al. (2018) Time Dependent and Independent Effects of Thyroid Hormone Administration Following Myocardial Infarction in Rats. Molecular Medicine Reports, 18, 864-876.
|
[14]
|
Chang, X., Zhang, S., Zhang, M., et al. (2018) Free Triiodothyronine and Global Registry of Acute Coronary Events Risk Score on Predicting Long-Term Major Adverse Cardiac Events in STEMI Patients Undergoing Primary PCI. Lipids in Health and Disease, 17, 234. https://doi.org/10.1186/s12944-018-0881-7
|
[15]
|
Yu, T., et al. (2018) Value of the fT3/fT4 Ratio and Its Combination with the GRACE Risk Score in Predicting the Prognosis in Euthyroid Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Prospective Cohort Study. BMC Cardiovascular Disorders, 18, 181.
|
[16]
|
She, J.Q., Feng, J.H., Deng, Y.Y., et al. (2018) Correlation of Triiodothyronine Level with In-Hospital Cardiac Function and Long-Term Prognosis in Patients with Acute Myocardial Infarction. Disease Markers, 2018, Article ID: 5236267. https://doi.org/10.1155/2018/5236267
|
[17]
|
Brozaitiene, J., Mickuviene, N., Podlipskyte, A., et al. (2016) Relationship and Prognostic Importance of Thyroid Hormone and N-Terminal Pro-B-Type Natriuretic Peptide for Patients after Acute Coronary Syndromes: A Longitudinal Observational Study. BMC Cardiovascular Disorders, 16, 45. https://doi.org/10.1186/s12872-016-0226-2
|
[18]
|
de Castro Alexandre, L., Fernandes, R.O., Ortiz, V.D., et al. (2018) Thyroid Hormones Decrease the Proinflammatory TLR4/NF-κβ Pathway and Improve Functional Parameters of the Left Ventricle of Infarcted Rats. Molecular and Cellular Endocrinology, 461, 132-142. https://doi.org/10.1016/j.mce.2017.09.003
|
[19]
|
Ortiz, V.D., de Castro Alexandre, L., Campos, C., et al. (2016) Effects of Thyroid Hormones on Aortic Tissue after Myocardial Infarction in Rats. European Journal of Pharmacology, 791, 788-793.
https://doi.org/10.1016/j.ejphar.2016.10.022
|
[20]
|
Cokkinos, D.V. and Chryssanthopoulos, S. (2016) Thyroid Hormones and Cardiac Remodeling. Heart Failure Reviews, 21, 365-372. https://doi.org/10.1007/s10741-016-9554-7
|
[21]
|
Corssac, G.B., et al. (2016) Thyroid Hormones Effects on Oxidative Stress and Cardiac Remodeling in the Right Ventricle of Infarcted Rats. Life Sciences, 146, 109-116. https://doi.org/10.1016/j.lfs.2015.12.052
|
[22]
|
Iwamiya, T., Segard, B.D., Matsuoka, Y., et al. (2020) Human Cardiac Fibroblasts Expressing VCAM1 Improve Heart Function in Postinfarct Heart Failure Rat Models by Stimulating Lymphangiogenesis. PLoS ONE, 15, e0237810.
https://doi.org/10.1371/journal.pone.0237810
|
[23]
|
Einfeldt, M.N., Olsen, A.-M.S., Kristensen, S.L., et al. (2019) Long-Term Outcome in Patients with Heart Failure Treated with Levothyroxine: An Observational Nationwide Cohort Study. The Journal of Clinical Endocrinology & Metabolism, 104, 1725-1734. https://doi.org/10.1210/jc.2018-01604
|
[24]
|
Rajagopalan, V., Zhang, Y.H., Ojamaa, K., et al. (2016) Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects. PLoS ONE, 11, e0151413.
https://doi.org/10.1371/journal.pone.0151413
|
[25]
|
Ortiz, V.D., Türck, P., Teixeira, R., et al. (2019) Carvedilol and Thyroid Hormones Co-Administration Mitigates Oxidative Stress and Improves Cardiac Function after Acute Myocardial Infarction. European Journal of Pharmacology, 854, 159-166. https://doi.org/10.1016/j.ejphar.2019.04.024
|
[26]
|
Zhang, K., Tang, Y.-D., Zhang, Y.H., et al. (2018) Comparison of Therapeutic Triiodothyronine versus Metoprolol in the Treatment of Myocardial Infarction in Rats. Thyroid, 28, 799-810. https://doi.org/10.1089/thy.2017.0544
|
[27]
|
Teixeira, R.B., Zimmer, A., de Castro, A.L., et al. (2018) Exercise Training versus T3 and T4 Hormones Treatment: The Differential Benefits of Thyroid Hormones on the Parasympathetic Drive of Infarcted Rats. Life Sciences, 196, 93-101. https://doi.org/10.1016/j.lfs.2018.01.018
|